This study is testing a new approach called MediNF (meditative neurofeedback) for people with moderate depression. MediNF involves 10 sessions of breath-focused meditation with real-time feedback on your brain activity to help improve performance. The study aims to see if this intervention can significantly reduce symptoms of depression. You might be able to join if you are 18 or older, have moderate depression, and do not have active substance abuse, psychotic disorders, bipolar disorder, or acutely suicidal behaviors. Researchers will measure your depression symptoms using the PHQ9 (a questionnaire) after 8 weeks to see how well MediNF works. The current status of this study is unclear.

Study design

This is an open-label, single-arm study, meaning all 27 participants will receive the MediNF intervention, and both you and the researchers will know what treatment you are getting.

What's involved

You would participate in 10 sessions of breath-focused meditative practice with frontal brain connectivity neurofeedback. Your depression symptoms will be measured at 8 weeks.

Compensation

Not stated in the trial record.

Follow-up

Your depression symptoms will be measured at 8 weeks after starting the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.